Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Galapagos and Cellzome form kinase drug discovery collaboration
Kinases are an important class of drug targets often pursued by the pharmaceutical industry because of the vital role they play in regulating cancer and inflammatory diseases. Under
Kinases are an important class of drug targets often pursued by the pharmaceutical industry because of the vital role they play in regulating cancer and inflammatory diseases. Under
New flu cell culture vaccine manufacturing technology promises many advantages over traditional egg-based production, including greater reliability and a reduction in production time. The total investment of approximately
“The Mundogen generic business acquisition from GSK is in line with our M&A strategy to focus on the EU markets where we continue to see growth opportunities. The
Seroquel tablets, in the currently available immediate release formulation, are approved for the treatment of acute manic episodes associated with bipolar I disorder and the treatment of schizophrenia.
In the study, PhosLo was found to be more effective in controlling serum phosphorus than sevelamer, an established treatment for chronic renal failure marketed as Renagel by Genzyme
The new version of the drug, known as CAIV-T, can be stored in refrigerated conditions, an improvement over the current form of FluMist which must be kept frozen.
Scientists at the University of Pittsburgh and the Southern Research Institute in Birmingham, Alabama., have been collaborating with Novavax to test the company’s virus-like particle (VLP) vaccines for
The trial is being conducted in collaboration with the Dana-Farber/Partners Cancer Care (DFPCC), a joint venture non-profit consortium established by Massachusetts General Hospital, The Brigham and Women’s Hospital,
The device was developed in collaboration Professor Donna Davies and Dr Judith Holloway from the University’s school of medicine, and Philips Research. The University said that the next
Preliminary results from the trial indicate that inhaled TPI-ASM8 was safe and well tolerated and demonstrated protection in early and late stage allergic responses in patients with asthma.